BioAtla, Inc. ( BCAB) - Stock Earnings
Stock symbol BCAB is outdated, potentially delisted? Maybe it is available on other exchange?
BCAB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
BCAB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -9.8 million USD | 2.0 million USD |
| 2026Q1 | -6.3 million USD | — USD |
| 2026Q2 | 452000 USD | 6.5 million USD |
| 2026Q4 Est. | — | — |
BCAB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -123.5 million USD | — USD |
| 2024 | -69.8 million USD | 11.0 million USD |
| 2025 | -59.6 million USD | 2.0 million USD |
| 2026 Est. | — | — |
BCAB
Price: $1.74
52 week price:
Earnings Per Share: -25.07 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 285700
Market Capitalization: 5.1 million